This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
FDA And EMA Evaluate Claims As Nitrosamine Worries Turn To Zantac
Aimmune’s Palforzia Gains US FDA Panel Nod But Faces REMS Restrictions
Kyprolis-Plus-Darzalex Boosts Amgen's Myeloma Pipeline, After MCL-1 Drugs' Clinical Holds
BACE Hopes Finally Fizzle As Biogen/Eisai End Elenbecestat Alzheimer's Studies